Literature DB >> 26752471

Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.

Dario Sorrentino1.   

Abstract

Little is known on the natural history of Crohn's disease (CD) before diagnosis. By the time the patient is diagnosed, the disease has often produced considerable damage to the intestinal mucosa and sometimes other organs. Such period before diagnosis might involve both a silent and a symptomatic phase. The silent phase, or preclinical CD, might last several years after the biological disease onset. Evidence is accumulating that the symptomatic phase might also go undiagnosed for months or years. In fact, for each established case of CD, there are probably several undiagnosed cases, a classic iceberg phenomenon of disease. Such status quo--lagging behind diagnostic standards for many other diseases--effectively hampers efforts to block disease evolution and the development of complications. This is no longer tenable because CD is a debilitating, severe, and costly affection, whose incidence is rapidly rising worldwide. Here, we will review what is currently known on preclinical and undiagnosed CD and what could be done to improve accuracy and timeliness of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26752471     DOI: 10.1097/MIB.0000000000000612

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.

Authors:  James R Irwin; Emma Ferguson; Lisa A Simms; Katherine Hanigan; James D Doecke; Daman Langguth; Ashley Arnott; Graham Radford-Smith
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

2.  The Coming of Age of Inflammatory Bowel Diseases in Asia.

Authors:  Dario Sorrentino
Journal:  Inflamm Intest Dis       Date:  2017-09-27

3.  Disease Trajectories for Hidradenitis Suppurativa in the Danish Population.

Authors:  Rune Kjærsgaard Andersen; Isabella Friis Jørgensen; Roc Reguant; Gregor Borut Ernst Jemec; Søren Brunak
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

4.  Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.

Authors:  Kyunghwan Oh; Eun Hye Oh; Seunghee Baek; Eun Mi Song; Gwang-Un Kim; Myeongsook Seo; Sung Wook Hwang; Sang Hyoung Park; Dong-Hoon Yang; Kyung-Jo Kim; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Byong Duk Ye
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

5.  Perinatal and Antibiotic Exposures and the Risk of Developing Childhood-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Based on a Population-Based Birth Cohort.

Authors:  Cristina Canova; Jonas F Ludvigsson; Riccardo Di Domenicantonio; Loris Zanier; Claudio Barbiellini Amidei; Fabiana Zingone
Journal:  Int J Environ Res Public Health       Date:  2020-04-02       Impact factor: 3.390

Review 6.  Diagnosis and natural history of preclinical and early inflammatory bowel disease.

Authors:  Iago Rodríguez-Lago; Yamile Zabana; Manuel Barreiro-de Acosta
Journal:  Ann Gastroenterol       Date:  2020-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.